ArticleTherapeutic advances in gastroenterology2025

Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS study.

Frederick Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.